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Axonal growth during normal development and axonal regeneration rely on the
action of many receptor signaling systems and complexes, most of them located in
specialized raft membrane microdomains with a precise lipid composition. Cholesterol
is a component of membrane rafts and the integrity of these structures depends on the
concentrations present of this compound. Here we explored the effect of cholesterol
depletion in both developing neurons and regenerating axons. First, we show that
cholesterol depletion in vitro in developing neurons from the central and peripheral
nervous systems increases the size of growth cones, the density of filopodium-like
structures and the number of neurite branching points. Next, we demonstrate that
cholesterol depletion enhances axonal regeneration after axotomy in vitro both in a
microfluidic system using dissociated hippocampal neurons and in a slice-coculture
organotypic model of axotomy and regeneration. Finally, using axotomy experiments in
the sciatic nerve, we also show that cholesterol depletion favors axonal regeneration
in vivo. Importantly, the enhanced regeneration observed in peripheral axons also
correlated with earlier electrophysiological responses, thereby indicating functional
recovery following the regeneration. Taken together, our results suggest that cholesterol
depletion per se is able to promote axonal growth in developing axons and to
increase axonal regeneration in vitro and in vivo both in the central and peripheral
nervous systems.
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INTRODUCTION
Axonal guidance during the development of the nervous system is thought to be highly
regulated through interactions of transmembrane receptors with attractive, repulsive, and
trophic cues. Similar mechanisms regulate axonal regeneration after injury. The transected axon
undergoes morphological changes to form the growth cone, a highly dynamic structure that
senses the environment and leads the regenerative growth (Allodi et al., 2012). Membrane
receptors localized in the growth cone have an important role in axonal signaling (Guirland
et al., 2004; Kamiguchi, 2006). The regenerative shift of axotomized neurons is promoted
by injury-induced signals, which stimulate the transcription of various trophic factors,
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adhesion molecules, growth-associated proteins and structural
components needed for axonal regrowth and cell survival (Rishal
and Fainzilber, 2014).
Many intrinsic and extrinsic signals can promote or inhibit
axonal regeneration. Due to the importance of these signals
during axonal degeneration and regeneration after peripheral
nerve injury, microdomains in the membrane that cluster a range
of proteins and molecules related to cellular signaling may play a
key role in the regulation of these pathways. In particular, lipid
rafts have been described as cholesterol-enriched cell membrane
microdomains that compartmentalize lipids and protein to form
signaling platforms (Golub et al., 2004).
Cholesterol is a major component of the nervous system,
being essential for normal brain development. The brain is the
most cholesterol-rich organ, containing about 20% of the body’s
total cholesterol (Bjorkhem and Meaney, 2004). Under normal
physiological situations and because plasma lipoproteins do not
cross the intact blood-brain barrier, nearly all cholesterol in the
brain is synthesized in situ (Dietschy and Turley, 2001). Brain
cholesterol is an important structural component of cellular
membranes and myelin. It is also required for the synthesis of
steroid hormones and for the organization of lipid rafts, which
are involved in many aspects of brain function, such as growth
factor signaling, synapse and dendritic formation (Goritz et al.,
2005), and axon elongation and guidance (de Chaves et al., 1997).
Here we studied the effects of altered membrane integrity by
reducing the cholesterol content in the axons of three neuronal
systems, namely hippocampal and cerebellar external granular
layer (EGL) cells as a Central Nervous System (CNS) example,
and the dorsal root ganglion (DRG) neurons as a Peripheral
Nervous System (PNS) example. We show that depletion of
cholesterol leads to increased sizes of growth cones, filopodial
extensions and neurite length. Moreover, we also demonstrate
that cholesterol membrane and raft disruption increase the
regenerative capacity of axons after axotomy both in vitro and
in vivo and enhance muscle and sensory re-innervation of
distal targets. On the basis of our findings, we propose that
acute reduction of neuronal cholesterol emerges as a potential
therapeutic strategy to improve regenerative outcomes after
peripheral nerve lesion.
MATERIALS AND METHODS
Reagents and Antibodies
The following antibodies were used: anti-GFP (A11122,
Invitrogen); anti-IIIβ-tubulin (MMS-435P, Covance); anti-
growth associated protein 43 (GAP43) (AB5220, Millipore);
anti-myelin basic protein antibody (MBP) (ab7349, Abcam);
anti-neurofilament H (NF-H) (AB5539, Millipore); Donkey anti-
Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody
Alexa Fluor 488 (A-21202, Thermo Fisher); Donkey anti-Rabbit
IgG (H+L) Highly Cross-Adsorbed Secondary Antibody Alexa
Fluor 488 (A-21206, Thermo Fisher); Goat anti-Chicken IgY
(H+L) Alexa Fluor 488 (A-11039, Thermo Fisher), Biotinylated
Horse anti-rabbit IgG (BA-1000, Vector); Biotinylated Goat
anti-rat IgG (BA-9400, Vector), Streptavidin-Biotinylated HRP
Complex (RPN1051, GE Healthcare); and Streptavidin-Alexa
Fluor 594 (S32356, Thermo Fisher).
The following drugs and reagents were used: poly-D-Lysine
(P7280, Sigma); laminin (L2020, Sigma); Nystatin dihydrate
(N4014, Sigma); Cholesterol Oxidase Streptomyces sp. (ChOx)
(228250, Calbiochem); Methyl-β-cyclodextrin (MβCD) (C4555,
Sigma); DMSO (D5879, Sigma); phalloidin – TRITC (P1951,
Sigma); biocytin (B4261, Sigma); Cholera Toxin Subunit
B (Recombinant) Alexa Fluor 594 (CTxB-594) (C34777,
Life BioSciences).
Primary Cultures
Hippocampus
Primary cultures of mouse hippocampi were prepared from E16-
E17. Pregnant CD1mice were sacrificed by cervical dislocation,
and the fetuses were collected in a PBS-glucose 0.3% solution
and then decapitated. Hippocampi were isolated and trypsinized
for 6 min at 37◦C. Trypsin was then neutralized with FBS
and incubated with DNase for 10 min at 37◦C. Neurons
were then centrifuged at 800 rpm for 5 min, resuspended
and plated in pre-coated culture glasses with poly-D-lysine in
medium containing Neurobasal (w/o L-glutamine, w/Phenol
Red; GIBCO, 21103-049), 1% penicillin/streptomycin (GIBCO,
15140-122), 1% glutamine (GIBCO, 25030-024) and 2% B27
(GIBCO, 17504-044).
Cerebellum
Primary cultures of cerebellums were prepared from P4–P5
CD1 mice sacrificed by decapitation. Cerebellums were isolated,
mechanically disaggregated and trypsinized as previously
described. After centrifugation, neurons were resuspended in
2 mL of DMEM, and EGL were isolated by centrifugation
in a percol gradient. After a wash centrifugation, EGL
were plated in pre-coated culture glasses with poly-D-lysine
in medium containing DMEM (GIBCO, 41966-029), 1%
penicillin/streptomycin (GIBCO, 15140-122), 1% glutamine
(GIBCO, 25030-024), 4.5% D-(+)-Glucose (Sigma, G-8769), 5%
NHS (GIBCO, 26050-088), and 10% FBS (GIBCO, 16000-044)
for 24 h, and then NHS and FBS were replaced by 2% B27
(GIBCO, 17504-044) and 1% N2 (GIBCO, 17502-048).
Dorsal Root Ganglion (DRG)
Primary cultures of DRG neurons were prepared from E13–E14
mice. Pregnant CD1 mice were sacrificed by cervical dislocation,
and the fetuses were collected and decapitated. DRG neurons
were isolated and trypsinized as previously described. After
centrifugation, neurons were resuspended and plated in
pre-coated culture glasses with poly-D-lysine and laminin
in medium containing DMEM (GIBCO, 41966-029), 1%
penicillin/streptomycin (GIBCO, 15140-122), 1% glutamine
(GIBCO, 25030-024), 0.06% D-(+)-Glucose (Sigma, G-8769),
0.0045% NaHCO3 (GIBCO, 25080-060), 2% B27 (GIBCO,
17504-044) and 5 µg/ml NGF.
Organotypic entorhino-hippocampal slice cultures were
obtained from P0 actin-GFP and WT mice sacrificed by
decapitation. Horizontal sections 325 µm thick containing
both the entorhinal cortex (EC) and the hippocampus were
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obtained by cutting tissue pieces in a chopper (McIlwain Tissue
Chopper, Standard Table, 220V, Prod 10180-220). Slices were
laid on a porous Millicell CM plate culture insert (Millipore,
PICM03050) and incubated using the interface culture technique.
The medium comprised 35.5% Neurobasal, 25% MEM powder,
25% NHS (GIBCO, 26050-088), 12.5%HBSS (w/Mg, w/Phenol
Red, GIBCO, 24020-083), 0.5% D-(+)-glucose (Sigma, G-8769),
1% glutamine (GIBCO, 25030-024), 1% penicillin/streptomycin
(GIBCO, 15140-122), 1.1% sodium pyruvate (Sigma, P2256-
5G), 0.04% NaHCO3 (GIBCO, 25080-060), 2% B27 (GIBCO,
17504-044) and 1% N2 (GIBCO, 17502-048). The medium was
changed every 2 days. After 21 days in vitro (DIV), axotomy
was performed between the EC and the hippocampus with a
needle, and WT hippocampi were put with EC GFP. The cultures
were treated for 10 days with Nystatin or control medium
and fixed with 4% paraformaldehyde (PFA) for 1h. Cultures
were cut into 60 µm slices with a vibratome (Leica VT 1000
S) and cryopreserved at −20◦C until immunohistochemistry
was performed.
Drug Treatments in vitro
Growth Cone and Filopodium Experiments
Hippocampal and EGL primary cultures were treated after 3 DIV
and DRG after 1 DIV with 2.5 µg/mL Nystatin for 10 min,
0.5 mM MβCD for 10 min or 2U ChOx for 2 h. They were then
incubated for an additional 30 min in culture media (Neurobasal
or DMEM) and then fixed in 4% PFA.
Axon Extension and Branching Experiments in DRG
Neurons
After 2 h in culture, 2.5 µg/mL Nystatin and 2U ChOx were
added to the media for 24 h and neurons were then fixed. After
22 h in vitro, and therefore 2 h before neurons were fixed, 0.5 mM
MβCD was added to the media.
Axotomy Experiments
Axotomy in microfluidic chambers (AX50010TC, Millipore)
was performed with a pipette connected to a vacuum pump.
Complete axotomy was verified in the inverted microscope.
Immediately after axotomy, 2.5 µg/mL Nystatin was added and
maintained in the culture for 3 days. In organotypic cultures,
5 µg/mL Nystatin was added to the media just after axotomy and
maintained for 10 days, changing the media every 2 days.
Animals and Surgical Procedures
To study the effect of cholesterol depletion on healthy mice,
10 OF1 female mice (20–25 g) were divided in two groups
and treated with saline (vehicle) or MβCD 1000 mg/kg/week
intraperitoneal (i.p.) during 1 month. To study the effect of
lipid raft disruption on peripheral nerve regeneration, 13 female
mice (25–30 g) were injured on the sciatic nerve and allowed
to regenerate for 1 month while receiving saline (n = 6) or
1000 mg/kg/week MβCD (n = 7) i.p. treatment.
To perform the nerve injury, animals were anesthetized by
i.p. injection of ketamine (90 mg/kg; Imalgene 500, Rhône-
Merieux, Lyon, France) and xylazine (10 mg/kg; Rompun, Bayer,
Leverkusen, Germany). The right sciatic nerve was surgically
exposed at the midthigh and carefully freed from adherences
to surrounding tissues. Afterwards, it was cut at 45 mm from
the tip of the 3rd toe and immediately repaired using two
epineurial sutures (10–0), maintaining the fascicular alignment
of the sciatic branches. Finally, the wound was sutured in planes
and disinfected. Animals were left to recover on a hot pad after
being returned to their cages. The left paw was left uninjured
as a control.
All the animals had food and water ad libitum and were
kept at a standard temperature (22 ± 2◦C) and under 12:12-h
light-dark cycles (300 lux/0 lux). The experimental procedures
followed the recommendations of the European Communities
Council Directive 2010/63/EU for the care and use of laboratory
animals and were approved by the Committee for Ethics on
Experimental Animal and Human Research of the Universitat
Autònoma de Barcelona.
Electrophysiology Tests
To test possible effects of MβCD on intact animals,
electrophysiological tests were performed every 7 days after
beginning of the treatment and for 4 weeks. To monitor
peripheral nerve regeneration, electrophysiological tests were
performed at 14, 21, 25, 28, and 33 days post-injury (dpi).
Animals were anesthetized with pentobarbital (10 mg/kg) and
the sciatic nerve was stimulated using two needle electrodes
inserted percutaneously at the sciatic notch, applying single
rectangular pulses of 0.02 ms up to the voltage required to
obtain a maximal evoked response. The compound muscle action
potentials (CMAP, M wave) evoked by stimulation of motor
nerve fibers were recorded from the tibialis anterior (TA) and
plantar (PL) muscles with microneedle electrodes. All potentials
were amplified and displayed on a digital oscilloscope (Tektronix
450S; Tektronix, Beaverton, OR, United States) at the appropriate
settings for latency and amplitude measurements from the
baseline to the maximal negative peak. During the tests, the
animals were placed over a warmed flat coil controlled by a hot
water circulating pump to maintain body skin temperature.
Locomotion Evaluation
The DigiGait system (Mouse Specifics, Boston, MA,
United States) was used to assess locomotor performance
of healthy animals treated with MβCD or vehicle at weekly
intervals during treatment. The mice were forced to run over
the transparent belt of a motorized treadmill and recorded with
a high-speed video camera (80 frames/s) from below while
running at a constant treadmill velocity of 20 cm/s. A minimum
of 200 images were collected for each walking mouse containing
more than eight strides for each run and each video was analyzed
with the DigiGait software. The print length, and the toe spread
distance between toes 1–5 and toes 2–4 were measured, and the
sciatic functional index (SFI) between the right and the left paw
was calculated (Navarro, 2016).
Mechanical Algesimetry
The algesimetry tests for mechanical stimuli were performed
on both hindpaws every week along treatment in uninjured
animals. Sensibility to a non-noxious mechanical stimulus was
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measured by using an electronic Von Frey algesimeter (Bioseb,
Chaville, France). Mice were placed on a wire net platform in
plastic chambers 10 min before the experiment for habituation.
The hindpaw plantar surface was stimulated from the bottom
of the box by applying a 0.4 mm non-noxious pointed metal
probe to the central area of the paw, and then slowly increasing
the pressure until the mouse raised the paw, with a 35 g cut
off force to avoid skin damage. The mechanical nociceptive
threshold was taken as the mean of three measurements per
paw and the threshold was expressed as the force (in grams)
at which mice withdrew the paw in response to the stimulus
(Cobianchi et al., 2014).
Pinprick Test
Progression of nociceptive reinnervation of the hindpaw was
assessed at 14, 21, 25, 28, and 33 dpi by means of the pinprick test.
Awake animals were gently wrapped in a cloth with the injured
paw facing upward. The skin surface near C plantar pad and 4th
toe (more distal) were stimulated with a blunt needle with enough
intensity to indent the skin without damaging it (Cobianchi
et al., 2014). Each site was stimulated twice and responses were
recorded as positive only when clear pain reactions such as fast
withdrawal or vocalization were triggered. Positive responses
were taken as a sign of functional reinnervation of the skin.
Histology, Immunohistochemistry and
Immunocytochemistry
Neurons were fixed with a solution of 4% PFA in PBS for 10 min.
Subsequently, they were rinsed with PBS and permeabilized with
a solution of triton 0.1% X-100 in PBS for 10 min. Afterwards,
they were rinsed with PBS once more, and blocking solution
(NHS 10% in PBS) was added for 1 h at room temperature. After
blocking, the cells were incubated for 2 h with the respective
primary antibodies diluted in blocking solution. Unbound
primary antibodies were washed with PBS, and neurons were
incubated with the respective secondary antibodies in blocking
solution for 1 h at room temperature. For F-actin staining
after permeabilization, phalloidin diluted in PBS was added and
maintained for 30 min. Neurons were mounted using Mowiol.
Organotypic slices were rinsed with PBS with 0.5% Triton
three times, and were incubated for 2 h at room temperature with
blocking solution (10% NHS, 0.2M Glycine in PBS-Gelatin with
0.5%Triton). After blocking, the cells were incubated overnight
at 4◦C with the respective primary antibodies diluted in antibody
solution (5% NHS in PBS-Gelatin with 0.5%Triton). Unbound
primary antibodies were washed with PBS with 0.5% Triton, and
slices were incubated with the respective secondary antibodies in
antibody solution for 2 h at room temperature.
For the in vivo regeneration experiment, mice were
transcardially perfused with 4% PFA in PBS (0.1 M, pH
7.4) 1 month after beginning the treatment. Subsequently, the
sciatic nerve, spinal cord, L4 and L5 DRG neurons were removed,
postfixed for 24 h with PFA and cryopreserved in PB containing
30% of sucrose for immunohistochemistry analysis. Samples
were serially cut (15 µm) with a cryotome (Leica CM190) and
stored at−20◦C for further analysis.
For cholesterol depletion analysis, samples were defrosted for
30 min at room temperature and then rehydrated with PBS
for 5 min. DRG neurons were then incubated for 3 h at room
temperature with CTxB (1:200) in PBS. Slides were washed and
mounted using Mowiol.
For immunohistochemistry, samples were defrosted at room
temperature, blocked with PBS-specific animal serum, and
incubated overnight at 4◦C with the primary antibodies rabbit
anti- GAP43 (1:100), rat anti- MBP (1:200) and chicken anti-
NF-H (1:100). After washes, sections were incubated with the
respective biotinylated secondary antibody (1:200) for GAP43
and MBP and then for 1 h at room temperature with conjugated
Alexa Fluor streptavidin (1:200) or Alexa Fluor anti-chicken IgY.
Finally, sections were mounted with Mowiol containing DAPI for
nuclear staining.
Image Analysis
Images of primary cell cultures were taken in an epifluorescence
microscope (Eclipse Nikon E1000) with a 60× oil-immersion
objective. To take images from the in vitro axotomy experiments,
we used an inverted microscope (Olympus ScanR) with a
20× objective. For images of the organotypic cultures, we
used a confocal microscope (Leica TCS SP5) with a 20×
objective and a 20× objective with 2× zoom to quantify axon
regeneration. Images of the tibial nerve with MBP and NF-H
immunostaining were taken10 mm distally from the injury site
with an epifluorescence microscope (Eclipse Ni, Nikon) attached
to a digital camera (DS-Ri2, Nikon). Finally, we used a confocal
fluorescent microscope (Zeiss LSM 700) to acquire the images
from the SC and DRG tissue sections stained with GAP43, and
images were analyzed with ImageJ (Schneider et al., 2012). Briefly,
the area of the soma of at least 100 DRG neurons/animal and
10 motoneurons/animal were taken as ROI, and the integrated
density (mean gray value × area) was obtained. The mean value
obtained for each animal was used for comparison (Romeo-
Guitart et al., 2018).
Statistical Analysis
All in vitro experiments were done three times independently.
Data show means ± SEM. To analyze the statistics, we used
GraphPad software and applied ANOVA test for multiple
conditions or the Student’s t-test for two conditions. In vivo
results are presented as mean ± SEM and means were compared
with two-tailed, unpaired Student’s t-test, two-way ANOVA
followed by Tukey’s Multiple Comparison Test or Mantel–Cox
test. Differences were considered significant at p< 0.05.
RESULTS
Cholesterol Depletion Increases Growth
Cone Area and Number of Filopodia in
Hippocampal and EGL Cerebellar Axons
Growth cones play a key role during axonal growth and
guidance. First, we examined the effect of cholesterol depletion
on the morphological features of growth cones. To this end,
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we treated hippocampal and EGL neurons with two drugs that
efficiently reduce cholesterol in the cell membrane (Nystatin
and MβCD), and with ChOx, a cholesterol-depleting enzyme
(Figure 1) (Bolard, 1986; Cahuzac et al., 2006; Zidovetzki and
Levitan, 2007). Both neuron types were kept in culture for
3 DIV before being treated with the aforementioned drugs. In
hippocampal neurons, depletion of cholesterol driven by the
three drugs significantly increased the growth cone area identified
by phalloidin staining (Figures 1A,C). However, only Nystatin
increased this parameter in EGL neurons (Figures 1B,D).
Overall, our results show that cholesterol depletion increases the
growth cone area in hippocampal and EGL neurons in the CNS.
During the course of the experiments, we observed another
effect of cholesterol depletion, namely the development of
numerous filpodium-like extensions/branching points along
neurites. Filopodia, dynamic membranous structures driven
from the actin cytoskeleton, are necessary for axonal motility,
guidance, branching and regeneration. To determine the
importance of cholesterol in the formation of filopodium-
like structures, we again treated hippocampal and EGL
neurons with Nystatin, ChOx, and MβCD (Figure 2). The
filopodium-like structures were counted in discrete segments
of hippocampal and EGL axons (Figures 2A,B). Cholesterol
depletion induced by these drugs led to a significant increase
in the number of filopodium-like structures in both types of
neuron (Figures 2C,D).
These results indicate that a reduction in the cholesterol
content of the cell membrane of both types of neuron promoted
an increase in the number of filopodium-like structures
and branching. In contrast to the effect of these drugs on
growth cone area, these compounds enhanced the number of
filopodia/branches in hippocampal and EGL neurons.
Cholesterol Depletion Affects Growth
Cone Area, Number of Filopodia, and
Neurite Extension in DRG Neurons
To determine whether the effects of cholesterol depletion
observed in the CNS neurons can be extrapolated to the PNS, we
performed the same experiments using DRG neurons (Figure 3).
DRG neurons were isolated from mouse embryos at E13–14 and
treated after 1 DIV with cholesterol removal agents. Treatment
with Nystatin and ChOx led to an increase in growth cone
area in DRG neurons (Figures 3A,C), and the removal of
cholesterol with any of the three drugs enhanced the number of
filopodia (Figures 3B,D).
FIGURE 1 | Cholesterol depletion increases growth cone area in hippocampal neurons and EGL neurons. Examples of hippocampal (A) and EGL (B) growth cones
treated with control culture media, 2.5 µg/ml Nystatin, 2U ChOx, and 0.5 mM MβCD and stained with phalloidin. Growth cones areas from three independent
experiments were measured. Data represent means ± SEM (C,D). N = 150–250 growth cones in each condition (One-way ANOVA, Dunnett’s Multiple comparison
test ∗∗∗p < 0.0001). Scale bar 5 µm.
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FIGURE 2 | Cholesterol depletion increases filopodium-like structures in hippocampal neurons and EGL neurons. Examples of hippocampal (A) and EGL (B)
filopodium-like structures in axons treated with control culture media, 2.5 µg/ml Nystatin, 2U ChOx, and 0.5 mM MβCD and stained with phalloidin. The density of
filopodium-like structures was measured in discrete segments of axons in three independent experiments. Data represent means ± SEM (C,D). N = 150–250
neurons in each condition (One-way ANOVA, Dunnett’s Multiple comparison test ∗∗p < 0.01, ∗∗∗p < 0.0001). Scale bar 5 µm.
We also quantified the effect of cholesterol depletion on
neurite extension and branching (Figure 4). Treatments were
performed for 24 h in the case of Nystatin and ChOx and
for 2 h before fixation in the case of MβCD, as we observed
increased cell death with longer incubations with this drug. Only
the treatment with Nystatin increased the total length of DRG
neurites while ChOx and MβCD did not affect this parameter
(Figures 4A,B). We found that 24 h treatments with Nystatin and
ChOx led to a significant increase in the number of branching
points (Figures 4A,C).
These results suggest that pharmacological removal of
cholesterol from the cell membrane has similar effects on CNS
(hippocampal and cerebellar) and PNS (DRG) neurons. An acute
decrease in cholesterol levels per se increases growth cone area
and filopodia/branching point density in developing neurons.
Cholesterol Depletion Improves Axonal
Regeneration After Axotomy in vitro and
ex vivo
One of the hallmarks of CNS regeneration is the difficulty
to achieve the regrowth of damaged axons. This difficulty is
attributed mainly to the generation of an axon blocking “milieu.”
As we have shown that cholesterol depletion increases axonal
growth cone area and axonal extension, we next addressed, using
an in vitro and an ex vivo system, whether depletion of this lipid
enhances axonal regeneration.
First, E16 hippocampal neurons were seeded in a microfluidic
chamber (Figure 5) and neurons were axotomized. This chamber
allowed us to differentially treat the axons, on one side with
control medium and on the other with medium supplemented
with Nystatin applied immediately after axotomy (Figure 5D).
Axons treated with Nystatin showed a significant increase in
length when compared with those cultured in basal control
medium (Figures 5A–C).
These results suggest that the removal of cholesterol by
means of Nystatin enhances axon regeneration after axotomy
in vitro. We next used the ex vivo organotypic model of
axotomy and regeneration (del Rio and Soriano, 2010). Slice
co-cultures from P0 mouse hippocampi and the EC were
isolated and kept in culture for 21 days (Figure 6). Some
EC slices were obtained from actin-GFP transgenic mice. At
21 DIV, axotomy was performed sectioning the entorhino-
hippocampal connection (EHP) using a needle, and mixed
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FIGURE 3 | Cholesterol depletion affects growth cone area and the density of filopodia in DRG neurons. Examples of DRG growth cones (A) and filopodia (B)
incubated with control media, 2.5 µg/ml Nystatin, 2U ChOx, and 0.5 mM MβCD and stained with phalloidin. Growth cone areas and filopodia from three
independent experiments were measured. Data represent means ± SEM (C,D). N = 150–250 neurons in each condition (One-way ANOVA, Dunnett’s Multiple
comparison test ∗∗p < 0.01, ∗∗∗p < 0.0001). Scale bar 5 µm.
co-cultures were generated. The hippocampi from actin-GFP
co-cultures were removed and replaced by hippocampi from
WT mice organotypic cultures, thereby allowing the direct
visualization of regenerating GFP-positive EC-hippocampal
axons. Axotomized organotypic cocultures were treated with
Nystatin for 10 additional days (Figure 6A). In axotomized
co-cultures that were not treated with Nystatin, virtually
no regenerating axons (or very few) were found in the
SLM/ML layers, which are the layers of termination of the
EHP pathway (Figures 6B,D). In contrast, after Nystatin
treatment, we observed a 10-fold increase in the density
of regenerating EC axons present in the SLM/ML layers
(Figures 6C,D). Organotypic cultures treated with Nystatin
showed a normal morphology and distribution, and no evidence
of neuronal degeneration was appreciated (Figure 6C). In
another set of experiments, WT EC slice-cocultures were
generated and axotomized as described above (Figure 6A) and
regenerating EC axons were visualized by Biocytin injections
(del Rio and Soriano, 2010). Again, the number of regenerating
EHP axons was markedly increased by the incubation with
Nystatin. Together with the above results, the present findings
indicate that cholesterol depletion favors axonal regeneration
in vitro and ex vivo.
Treatment With MβCD Has No Effect on
Healthy Mice
The results of motor electrophysiological tests performed
showed that MβCD administration in vivo did not cause any
impairment in the mice. The M wave amplitude (Supplementary
Figures S1A,B) and latency (Supplementary Figures S1C,D)
of TA and PL muscles did not present significant differences
between MβCD treated and saline control groups. The walking
track test yielded no differences in the SFI between groups
(Supplementary Figure S1E). Finally, mechanical algesimetry
was performed to evaluate possible changes in nociception in
MβCD treated animals. Results showed no significant differences
between control and treated animals in pain threshold along time
(Supplementary Figure S1F).
Treatment With MβCD Alters the Integrity
of the Lipid Raft by Reducing the
Amount of Membrane Cholesterol
Our previous results suggest that cholesterol depletion is directly
involved in promoting axonal regeneration. However, we next
sought to determine the effect of acute reduction of cholesterol
levels in the in vivo model of peripheral nerve lesion and
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FIGURE 4 | Cholesterol depletion increases neurite elongation and branching in DRG neurons. Examples of DRG neurons incubated for long periods with control
media, 2.5 µg/ml Nystatin, 2U ChOx, and 0.5 mM MβCD (A) and immunolabeled with anti-βIII-tubulin. Total neurite extension and number of branching points in
each neuron were quantified in each condition in three independent experiments. Data represent means ± SEM (B,C). N = 30–60 neurons in each condition
(One-way ANOVA, Dunnett’s Multiple comparison test ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.0001). Arrows point cell body. Scale bar 100 µm.
regeneration. Cholesterol is a major component of lipid rafts,
which are specialized membrane microdomains that hold a
multitude of signaling receptors. It has recently been shown that
disruption of the raft by acute depletion of cholesterol promotes
regeneration and functional recovery after spinal cord injury
(Tassew et al., 2014). Thus, we first examined the integrity of
raft structures in DRG nerves after acute depletion of cholesterol
by treatment with MβCD. Contralateral DRG neurons of injured
mice treated with MβCD or saline were incubated with the CTxB.
This fraction of the toxin has a known affinity for ganglioside
GM1, a lipid raft-associated molecule (Schnaar et al., 2014) widely
used as a marker of the presence of cholesterol in the cellular
membrane and of lipid raft integrity. Fluorescent staining showed
clear CTxB labeling in the plasma membrane of DRG neurons
from animals that received vehicle for 1 month (Figure 7A) in
comparison with those treated with MβCD (Figure 7B).
Cholesterol Depletion Induced by MβCD
Increases GAP43 in Sensory Neurons
After Axotomy
To study the regenerative response in sensory (Figure 8A) and
motor (Figure 8B) neurons after nerve section, the expression
of the GAP43 was measured. GAP43 is expressed at high levels
during development and axonal regeneration, and it is considered
a crucial component of an effective regenerative response in the
nervous system, being used as a marker of regeneration in injured
axons. The results showed higher immunoreactivity for GAP43 in
DRG neurons in injured animals treated with MβCD compared
to those treated with vehicle (Figure 8C). This observation
indicates that cholesterol depletion after sciatic injury enhances
the neuronal regenerative program. No significant difference
was observed for motoneurons (Figure 8D). Moreover, myelin
staining of the regenerated nerve was conducted to assess
whether lipid raft disruption could affect axonal remyelination.
Qualitative assessment of both saline- and MβCD-treated
animals (Figure 8E) shows similar presence of myelin in nerve
fibers of both groups, thus indicating that lipid raft disruption did
not block remyelination after injury.
Cholesterol Depletion Induced by MβCD
Improves Muscle Reinnervation and
Sensory Responses in Mice
Electrophysiological tests performed to follow up nerve
regeneration after sciatic nerve section and repair showed a
progressive increase in the amplitude of the M wave of the
two muscles in both groups, thereby indicating progressive
reinnervation of the muscles by the regenerated axons. Although
no differences were seen for the proximal TA muscle, MβCD-
treated mice had significantly higher M wave amplitude of the
PL muscle than control animals at 33 days (Figures 9A,B),
indicative of greater reinnervation of the distal muscles. Values
of M wave latency did not show significant differences between
the two groups (Figures 9C,D).
No signs of autotomy, that could be indicative of neuropathic
pain, were found in any studied mice. Recovery of sensitivity
was studied by means of the pinprick test on areas of the paw
from proximal to distal region of the sciatic nerve innervation
territory (Cobianchi et al., 2014). In the C plantar pad, no
animals showed positive response at 21 days, and with time
more animals recovered sensory response without differences
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FIGURE 5 | Nystatin improves axon regeneration after axotomy in vitro. Examples of hippocampal axon regrowth at 24, 48, and 72 h after axotomy in control
condition (A) and in response to treatment with 2.5 µg/ml Nystatin (B). Axon lengths were measured in each condition. Data represent means ± SEM (C).
Schematic diagram of a microfluidic chamber (D). Cell bodies are in the central channel (white), axon growth through microfluidic channels (blue) to both sides (green
and red). After axotomy, control medium was applied on one side (red) and Nystatin on the other (green). N = 3 chambers (t-Test in each time point, ∗∗∗p < 0.0001).
Scale bar 50 µm.
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FIGURE 6 | Nystatin increases EC axon regeneration in organotypic cultures. (A) Schematic diagram that summarizes the experimental protocol. Slice co-cultures
from P0 actin-GFP and WT mice were isolated, as described in Section “Materials and Methods” and kept in culture 21 DIV. Axotomy of the EHP was performed,
and slices were treated for 10 DIV with control medium or 5 µg/ml Nystatin. (B) Representative examples of control hippocampal slices show virtually no regenerative
axons (upper panel) or very few regenerative axons (lower panel). (C) Examples of hippocampal slices treated with Nystatin show moderate axonal regeneration
(upper panel) or robust axonal regeneration (lower panel). Axons that cross a 250 µm line were counted in three random fields near the dentate gyrus in each slice.
Data represent means ± SEM (D). One dot corresponds to one slice (t-Test ∗p < 0.05). Scale bar 100 µm. ML, molecular layer; GL, granule cell layer; H, hilus.
between groups. However, in the 4th toe, which is the most
distal area, cholesterol-depleted mice showed positive response
earlier than injured controls, and at 33 dpi, 50% of the MβCD
group showed positive responses whilst only 12.5% of the vehicle-
treated animals did (Figures 9E,F).
DISCUSSION
Following axotomy, several metabolic changes occur in
injured neurons to reinnervate denervated targets and thus
ensure survival and regeneration. Moreover, a growth cone
is formed at the tip of growing axons, and this process
requires morphological and biochemical changes in the plasma
membrane, including membrane extension and remodeling. In
this context, cholesterol-rich lipid rafts, also called membrane
microdomains, play a key role as signaling platforms of both
growth-promoting and growth-inhibiting molecules. With
regard to the possible contribution of lipid rafts and cholesterol
to nerve regeneration, conflicting views can be found in the
literature. Some authors demonstrated that lipid rafts promote
axonal regeneration (Santuccione et al., 2005; Zhang et al., 2013)
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FIGURE 7 | MβCD disruption of lipid rafts in DRG neurons. (A,B) Representative images of the DRGs of animals treated with vehicle (A) and MβCD (B). Note the
absence of CTxB membrane staining in B after MβCD treatment, indicating lipid raft disruption. Scale bar: 100 µm.
while others claim that they have an inhibitory role (Vinson
et al., 2003; Hausott et al., 2011). These contradictions can be
explained by the fact that, in addition to a variety of proteins and
molecules that promote axonal regeneration, such as receptors
of neurotrophic factors, lipid rafts also contain proteins and
molecules that exert an inhibitory role, such as receptors of
myelin-associated proteins (Kappagantula et al., 2014). On the
other hand, there is also some discrepancy about the role of
lipid rafts in cell apoptosis. It is described that pro-apoptotic
receptors like Neogenin, FAS and its ligand, JNK, PKC, Src
kinases and a wide variety of lymphocyte-related receptors are
more functional when are localized in lipid rafts, inducing a line
of investigation in which lipid rafts are targets for chemotherapy
(George and Wu, 2012). However, receptors related with cell
survival, like Akt cascade, also depend on lipid rafts (George
and Wu, 2012). It has been shown that cholesterol depletion
with MβCD protects cerebellar neurons from apoptosis (Zhou
et al., 2012) and after spinal cord injury, lipid raft disruption
promotes cell survival due to a loss of function of Neogenin
(Tassew et al., 2014). In conclusion, some of these studies
were performed in vitro and sought to address the cellular
pathway or the signaling of a specific neurotrophin through
lipid rafts, and did not take into account all the trophic factors
and cell responses that occur in vivo, but instead focused on
single pathways.
In the present study, we show that cholesterol depletion in
juvenile cultured neurons increases the size of growth cones and
enhances neurite and axonal extension and the marked formation
of filopodium-like extensions in both central and peripheral
neurons. Although we did not address the underlying molecular
mechanisms, we believe that both the membrane fluidity induced
by cholesterol depletion and partial lipid raft disruption may
account for the effects observed, as extracellular matrix and
adhesion receptors are also grouped in lipid rafts (Leitinger
and Hogg, 2002; Decker and ffrench-Constant, 2004; Head
et al., 2014). In addition, the increased size of neurites suggests
that cholesterol depletion might be involved in the positive
regulation of the exocytotic machinery needed for neurite growth
(Ros et al., 2015).
Next, we addressed whether cholesterol depletion increases
the regrowth of axotomized neurons in two in vitro models:
dissociated hippocampal cultures and axotomized EC-
hippocampal slice cultures. In both cases, we found a marked
increase in the regenerative potential of lesioned axons,
again suggesting that cholesterol depletion not only increases
axonal length in developing axons but also axonal regrowth
and regeneration in vitro. In addition, the observation that
regenerated EC-hippocampal axons were correctly targeted to
the appropriate termination layers (SLM and ML) indicates
that cholesterol depletion does not alter the molecular
mechanisms involved in the guidance and targeting of these
axons to the hippocampus.
Membrane extension during axon growth after axotomy
requires the incorporation of new lipids to the tips of the
regenerating axons. Incorporated cholesterol in the axons of
peripheral neurons after axotomy comes from transported
cholesterol synthesized in the cell bodies of lesioned neurons
(de Chaves et al., 1997), and from recycled cholesterol from
cellular and myelin debris originated during the injury
(Goodrum, 1991; de Chaves et al., 1997). The existence of
multiple complementary mechanism to incorporate cholesterol
into the re-growing membranes suggest a redundancy in the
process of cholesterol reutilization. Our results in vitro and
in vivo suggest that acute and medium-term reduction of
cholesterol levels have positive effects for axon elongation and
regeneration after nerve injury. However, further studies are
required to evaluate long-term effects of systemic cholesterol
reduction. Secondary undesired effects associated with alteration
of membrane cholesterol levels should also have to be considered.
Previous reports have found that MβCD may alter crayfish
neuromuscular junction functioning in cold conditions (14◦C)
but not at 21◦C (Ormerod et al., 2012) and cholesterol depletion
in Caenorhabditis elegans results in decreased motility (Merris
et al., 2004). Moreover, reduction of membrane cholesterol
alters ion channel activity in sensory peripheral neurons (Saghy
et al., 2015), with direct consequences for their hypersensitivity
(Pristera et al., 2012) and the development of neuropathic
pain (Ferrari and Levine, 2015; Amsalem et al., 2018). As a
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FIGURE 8 | MβCD increases GAP43 expression in injured DRG neurons. (A,B) Detail of DRG (A, dashed line) and motoneurons (B, dashed line) analyzed for GAP43
expression. (C,D) Quantification of GAP43 positivity in DRG neurons (C) and motoneurons (D) from animals treated with vehicle or MβCD vs. Saline. (E) Detail of a
regenerated nerve stained for cell nuclei (blue), NF-H (green), and GAP43 (red) of saline- (top) and MβCD-treated (bottom) animals. Scale bar: 15 µm in (A,B); 50 µm
in (E). Student’s t-test, ∗∗p < 0.01.
consequence, electrophysiological tests, pain threshold tests
and locomotion studies were performed on healthy animals to
evaluate any possible effect derived from the systemic MβCD
administration and the consequent membrane cholesterol
depletion. Our results on healthy mice showed no significant
differences between treated and control animals with reported
values similar to those found in previous studies in the
literature (Verdu et al., 1996; Bruna et al., 2010; Ale et al.,
2016). Of particular interest, the algesimetry results showed no
indication of hyperalgesia in intact mice, and the absence of
autotomy in mice in the regeneration experiment also points
out that there was no increased pain sensitivity after lipid raft
disruption (Casals-Diaz et al., 2009). Therefore, although some
uncontrolled effect cannot be dismissed, 1 month of systemic
MβCD administration and lipid raft disruption did not alter
normal nervous system function in mice.
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FIGURE 9 | MβCD treatment accelerates motor and sensory functional recovery following sciatic nerve injury. (A–D) Electrophysiological results after nerve injury in
mice treated with vehicle or with MβCD. Results of CMAP amplitude (A,B) and latency (C,D) recorded in TA and PL at 14, 21, 25, 28, and 33 dpi. Data are shown as
the mean and SEM (bars). ∗p < 0.05 with two-way Anova and Bonferroni test. (E,F) Pinprick test results to analyze sensory reinnervation in the hindpaw pad C (E)
and 4th toe (F). Results show the percentage of animals with positive response in each area in the groups treated with vehicle or MβCD. p < 0.05 Mantel–Cox test
indicate differences in the proportion of mice with reinnervation.
We then studied the effect of cholesterol depletion on
peripheral nerve regeneration. To this end, we chose an in vivo
model of peripheral nerve injury to avoid focusing on a single
pathway or molecule, thus gaining a complete view of nerve
regeneration. Cholesterol depletion and lipid raft disruption
were achieved by means of treatment with MβCD (Zidovetzki
and Levitan, 2007), a cyclic oligosaccharide that has been
used as an antineoplastic (Grosse et al., 1998) and also as a
complexing agent in pharmacological applications (Upadhyay
et al., 2006). The latter use of MβCD is attributed to its
amphipathic properties, and molecules can be encapsulated
inside the cavity of cyclodextrins. Thus, MβCD may act not
only by extracting cholesterol from the plasma membrane and
disrupting lipid rafts but also by catalyzing neurotrophic factors
and favoring their uptake by neurons or glial cells that play a
role in peripheral nerve regeneration. This could explain the
increase in the number of GAP43-positive DRG neurons, an
observation that indicates that, after MβCD treatment, there
are more neurons able to regenerate or that have switched to a
regenerative state sooner.
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Our results indicate that lipid rafts are disrupted from the
cell membrane after MβCD treatment, as shown by the loss of
CTxB staining. CTxB has affinity for the GM1 ganglioside, a
member of the complex ganglioside family, which also includes
GD1 and GT1 (Schnaar et al., 2014), and it has been widely
used as a marker of lipid raft integrity (Kalka et al., 2001). It
has been reported that treatment with MβCD destabilizes the
link between the axon and myelin as a result of the reduction
of GD1 and GT1 in the membrane. These two gangliosides
act as a myelin-associated glycoprotein receptors (Vyas et al.,
2002) and, consequently, they mediate the inhibition of neurite
outgrowth. With lipid raft disruption by MβCD, gangliosides are
removed from the cell membrane and they cannot mediate the
inhibition of neurite outgrowth. This situation may confer the
axon with a greater capacity to regenerate. Thus, the increased
motor and sensory reinnervation we observed after axotomy and
treatment with MβCD is consistent with a reduction of GD1
and GT1 inhibition.
Moreover, other studies have reported that cholesterol
removal affects various modes of endocytosis (Rodrigues et al.,
2013). Endocytosis is a widely used mechanism for receptor
internalization from the cell membrane, and it has been
demonstrated that cholesterol and lipid rafts play key roles in
clathrin-independent endocytic (Lamaze et al., 2001) and in
clathrin-dependent endocytic mechanisms (Rodal et al., 1999).
Thus, with lipid raft alteration, endocytosis might be impaired,
thereby also remodeling the normal presence or removal of
different receptors at the cell surface. With cholesterol depletion
by MβCD, the endocytosis of neurotrophic factor receptors may
be inhibited (Hausott et al., 2011). As the improvement in motor
and sensory regeneration suggests, this inhibition would lead to
increased cell receptor availability at cell surface, thus facilitating
axon regeneration. On the other hand, MβCD treatment might
interfere with myelin as it has a high lipid and cholesterol content.
Indeed, deficient cholesterol biosynthesis in oligodendrocytes
delays myelination (Saher et al., 2005) and the maximal brain
cholesterol synthesis corresponds to the peak of myelination
process (Korade and Kenworthy, 2008). However, our results
indicate that MβCD treatment did not affect myelination of
the regenerated nerve fibers in the adult mice. Nevertheless,
a detailed histomorphometric quantification of the regenerated
axons might be needed for a quantitative evaluation of the degree
of remyelination after lipid raft disruption.
Finally, our results indicate that MβCD treatment accelerates
nerve regeneration after complete nerve lesion. The positive
effect was detected as faster and higher levels of reinnervation
of distal targets, such as plantar muscles, which are the most
discriminative for detecting differences in nerve regeneration
rate. Whether these results would be more pronounced after a
more severe nerve injury requires further attention.
The results of this study shed light on the role of lipid
rafts in peripheral nerve regeneration, although more research
is needed to elucidate the specific mechanisms affected by lipid
raft disruption. As this study was performed from a functional
perspective, a number of alterations may have been occurring.
On the one hand, we may have accelerated regeneration due
to an increase in myelin clearance and thus a decrease in
myelin-associated inhibitory agents. On the other, the beneficial
effect might be due to an alteration of membrane ganglioside ratio
or because lipid raft disruption promotes an environment that is
favorable for neuron regeneration.
In conclusion, we have found that lipid raft disruption
increases axonal growth in young neurons in vitro, enhances
axonal regeneration in two in vitro models, and promotes
peripheral nerve regeneration. Our results support the notion
that these membrane microdomains play an important role in
the signaling responsible for determining neural growth during
development, as well as for nerve degeneration and regeneration
after injury. This could be important because many pathways
and molecules are involved in the processes that occur after
nerve injury, and the environment plays a key role in the
success or failure of nerve regeneration and functional recovery.
However, caution should be taken before the translationability
of our results. Considering the slow rate of nerve regeneration,
in humans with considerable nerve length, target reinnervation
may need several months to year. The possible effects of
long-term lipid raft disruption treatment pointed above need
to be investigated in preclinical models before any potential
clinical application.
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FIGURE S1 | Electrophysiological, locomotion and algesimetry tests performed
after vehicle or MβCD treatment in uninjured mice. (A–D) Electrophysiological
results in mice. Results of CMAP amplitude (A,B) and latency (C,D) recorded in
TA and PL muscles at 7, 14, 21, and 28 days after beginning of treatment. (E) Plot
of the SFI obtained in walking track test. (F) Algesimetry test results during the
4 weeks of treatment.
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